☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
johnson & johnson
Johnson & Johnson’s Sirturo Gains the US FDA & EC’s Approval to Treat Pulmonary Tuberculosis
July 3, 2024
Johnson & Johnson Reports sBLA Submission of Tremfya to the US FDA for Treating Crohn’s Disease
June 21, 2024
Johnson & Johnson Reports the BLA Submission of SC Amivantamab to the US FDA for Treating Non-Small Cell Lung Cancer
June 18, 2024
Johnson & Johnson Reports P-III (MDD3001) Study Data of Seltorexant for Treating Major Depressive Disorder
May 30, 2024
Johnson & Johnson to Acquire Numab's Yellow Jersey Therapeutics for an Aggregate of ~$1.25B
May 29, 2024
Johnson & Johnson to Expand its Dermatology Portfolio Through the Acquisition of Proteologix
May 17, 2024
Load more...
Back to Home